Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage
Olympus announced today that it has launched its SecureFlex single-use fine needle biopsy device in Europe and Japan.
Medical Microinstruments Inc. (MMI) says its robotics system has been used for the first microsurgical intracranial brain surgeries.
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
EndoQuest Robotics recently announced the completion of the first procedure performed by a gastroenterologist in its PARADIGM trial.
Kardium announced today that it completed the first commercial procedures using its Globe pulsed field ablation (PFA) system.
Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.
MADISON, Wis., Sept. 26, 2025 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adaptive radiotherapy with the introduction of the Accuray Stellar™* Solution. Initially for the U.S. market, the new Accuray technology is not just a system, it’s a solution, comprised of a comprehensive tool set designed to empower clinical teams to address the evolving treatment needs of patients undergoing radiotherapy.